Star power entices wrong people

Article

When "Today Show" host Katie Couric underwent a televised virtual colonoscopy in 2000, she probably didn't expect that her endorsement would have an influence on the wrong people.

When "Today Show" host Katie Couric underwent a televised virtual colonoscopy in 2000, she probably didn't expect that her endorsement would have an influence on the wrong people.

Numerous people younger than 50 responded to Couric's call for colon screening, reflecting her audience's demographics, according to a University of Michigan study. National guidelines recommend the test every 10 years for people 50 and older.

The public's blind trust in celebrity testimony contravenes standards that call for balanced dialogue, said Dr. Robin J. Larson, an instructor of medicine at Dartmouth Medical School.

Larson found that one-quarter of women and two-thirds of men surveyed were more likely to get a mammogram and a colonoscopy, respectively, because of celebrity endorsement (J Natl Cancer Inst 2005;97[9]: 693-695).

"Do these messages influence people most likely to benefit, or do they influence people for whom the benefits are not thought to outweigh the harms, such as Katie Couric, who was not of screening age or high risk?" Larson asked.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.